| Minimum information reporting in bio–nano experimental literature M Faria, M Björnmalm, KJ Thurecht, SJ Kent, RG Parton, M Kavallaris, ... Nature nanotechnology 13 (9), 777-785, 2018 | 539 | 2018 |
| Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems BJ Boyd, DV Whittaker, SM Khoo, G Davey International journal of pharmaceutics 309 (1-2), 218-226, 2006 | 376 | 2006 |
| Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure YD Dong, I Larson, T Hanley, BJ Boyd Langmuir 22 (23), 9512-9518, 2006 | 353 | 2006 |
| Stimuli responsive liquid crystals provide ‘on-demand’drug delivery in vitro and in vivo WK Fong, T Hanley, BJ Boyd Journal of Controlled Release 135 (3), 218-226, 2009 | 340 | 2009 |
| Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions X Mulet, BJ Boyd, CJ Drummond Journal of colloid and interface science 393, 1-20, 2013 | 324 | 2013 |
| Characterisation of drug release from cubosomes using the pressure ultrafiltration method BJ Boyd International journal of pharmaceutics 260 (2), 239-247, 2003 | 304 | 2003 |
| Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems BJ Boyd, CAS Bergström, Z Vinarov, M Kuentz, J Brouwers, P Augustijns, ... European Journal of Pharmaceutical Sciences 137, 104967, 2019 | 301 | 2019 |
| Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation CJH Porter, AM Kaukonen, BJ Boyd, GA Edwards, WN Charman Pharmaceutical research 21, 1405-1412, 2004 | 292 | 2004 |
| Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine CJH Porter, AM Kaukonen, A Taillardat-Bertschinger, BJ Boyd, ... Journal of pharmaceutical sciences 93 (5), 1110-1121, 2004 | 242 | 2004 |
| Peptide-based biosensors Q Liu, J Wang, BJ Boyd Talanta 136, 114-127, 2015 | 239 | 2015 |
| Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations AM Kaukonen, BJ Boyd, CJH Porter, WN Charman Pharmaceutical research 21, 245-253, 2004 | 232 | 2004 |
| Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs KWY Lee, TH Nguyen, T Hanley, BJ Boyd International journal of pharmaceutics 365 (1-2), 190-199, 2009 | 226 | 2009 |
| An overview of 3D printing technologies for soft materials and potential opportunities for lipid-based drug delivery systems K Vithani, A Goyanes, V Jannin, AW Basit, S Gaisford, BJ Boyd Pharmaceutical research 36, 1-20, 2019 | 225 | 2019 |
| Drug release from nanomedicines: selection of appropriate encapsulation and release methodology SJ Wallace, J Li, RL Nation, BJ Boyd Drug delivery and translational research 2, 284-292, 2012 | 224 | 2012 |
| Evaluating the link between self-assembled mesophase structure and drug release S Phan, WK Fong, N Kirby, T Hanley, BJ Boyd International journal of pharmaceutics 421 (1), 176-182, 2011 | 224 | 2011 |
| Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration TH Nguyen, T Hanley, CJH Porter, BJ Boyd Journal of controlled release 153 (2), 180-186, 2011 | 218 | 2011 |
| Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected … GA Kossena, BJ Boyd, CJH Porter, WN Charman Journal of pharmaceutical sciences 92 (3), 634-648, 2003 | 218 | 2003 |
| Steric stabilisation of self-assembled cubic lyotropic liquid crystalline nanoparticles: high throughput evaluation of triblock polyethylene oxide-polypropylene oxide … JYT Chong, X Mulet, LJ Waddington, BJ Boyd, CJ Drummond Soft Matter 7 (10), 4768-4777, 2011 | 211 | 2011 |
| Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties LM Kaminskas, BJ Boyd, CJH Porter Nanomedicine 6 (6), 1063-1084, 2011 | 209 | 2011 |
| Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38 V Bala, S Rao, BJ Boyd, CA Prestidge Journal of controlled release 172 (1), 48-61, 2013 | 207 | 2013 |
